Immunotech inc stock
Witryna6 kwi 2024 · Of the 21 institutional investors that purchased AIM ImmunoTech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Morgan Stanley ($1.51M), Renaissance Technologies LLC ($0.48M), BlackRock Inc. ($0.47M), State Street Corp ($0.17M), Dimensional Fund Advisors LP … Witryna2 dni temu · Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry OCALA, Fla., …
Immunotech inc stock
Did you know?
Witryna11 kwi 2024 · The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AIM ImmunoTech Inc 50-day moving average is $0.4869. WitrynaComplete AIM ImmunoTech Inc. stock information by Barron's. View real-time AIM stock price and news, along with industry-best analysis.
Witryna12 kwi 2024 · Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry. OCALA, Fla., April 12, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and … Witryna31 mar 2024 · AIM ImmunoTech Inc. comunicó los resultados de las ganancias para el año completo finalizado el 31 de diciembre de 2024. Para el año completo, la empresa declaró unos ingresos de 0,141 millones de USD frente a …
Witryna7 kwi 2024 · Registrant’s telephone number, including area code: (352) 448-7797 AIM Immunotech Inc. (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General … WitrynaAIM ImmunoTech Inc stock price live 0.438, this page displays NYSE AIM stock exchange data. View the AIM premarket stock price ahead of the market session or …
Witryna12 kwi 2024 · AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly …
Witryna7 kwi 2024 · The data shows that as of Jan 30, 2024 short interest in AIM ImmunoTech Inc. (AIM) stood at 1.71% of shares outstanding, with shares short rising to 0.55 … green house model memory careWitrynaAIM ImmunoTech Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AIM updated stock price target summary. greenhouse model aged careWitryna27 mar 2024 · AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and viral diseases — including COVID-19, the disease caused by the SARS-CoV-2 virus — today announced that it … fly blockerWitrynaAIM ImmunoTech Shareholders Elect All Three Company Director Nominees at 2024 Annual Meeting. OCALA, Fla., November 03, 2024--AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today announced that shareholders have re-elected all three of the Company’s directors, Stewart L. Appelrouth, Thomas K. … fly black nubian queenWitryna11 kwi 2024 · Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry. OCALA, Fla., April 12, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the research and … greenhouse misting timerWitryna12 kwi 2024 · About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat … fly blade pricingWitrynaOctober 21, 2024 Fourth Amendment to Agreement of Sale and Purchase with Acellories, Inc * Amendment to the November 14, 2024 Second Amended and Restated Rights Agreement as of November 9, 2024, by and between AIM ImmunoTech Inc. (f/k/a Hemispherx Biopharma, Inc.) and American Stock Transfer & Trust Company, LLC. fly black ink crew chicago